Pharmaceuticals

FDA Approves Insulet’s Omnipod Automated Insulin Delivery System for People with Type 2 Diabetes

bexib
By bexib 0 Min Read

With the expanded indication, Omnipod becomes the first automated insulin delivery system approved for the management of both type 1 and type 2 diabetes.

You Might Also Like

FDA Approves First Epinephrine Nasal Spray for Type I Allergic Reactions, Including Anaphylaxis

Novo Holdings acquires majority stake in Single-Use Support, expanding life science tools and diagnostics portfolio

Pharma Pulse 5/16/24: World Courier President talks supply chain risk mitigation, Walgreens brand naloxone available online and in stores, more

Researchers find CAR enhancer therapy may help overcome cancer recurrence

New study reveals how brain cell communication is linked to Alzheimer’s disease

Share This Article
Previous Article Movers and Shakers: Wells Fargo Appoints Two New Technology Leaders
Next Article Fog of War and Narrative, Israel and Hezbollah Attacks Edition
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

The countdown to the reopening of the iconic Delano Miami Beach begins
Hospitality & Tourism
Remembering Maker Faires in 2024?
Manufacturing
Top 5 Open Banking Stories of 2024
Banking
Ecommerce SEO Pros on AI, Strategies for 2025
Retail & E-commerce